Inventvacc was founded by Dr. Kapre & Mr. Pradip Ghate in 2016 to develop vaccines for rare diseases currently affecting more than 400 million people worldwide.
Our mission and focus is to empower healthy living by developing unique, efficacious and affordable vaccines for the populations most in need. Over the years, the company has grown from a small R&D lab, operating out of Vancouver, Canada, to a multinational commercial operations with an innovative pipeline.
InventVacc provides high-quality, cost-effective vaccines.
Our global approach not only provides high-quality and innovative products to protect against the world’s deadliest diseases but it also help people address health inequalities and empower people to live healthy lives.
We leverage the best of vaccine technology, science and manufacturing to prevent devastating infectious disease.
Company Details
- Employees
- 3
- Founded
- -
- Address
- 960 – 1111 Melville Street, Vancouver,bc V6e 3v6,canada
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.inventvacc.com
- Keywords
- Biotechnology, Vaccine, Manufacturing, Healthcare, Commercial, Research and development, Rare disease, Sales, Clinical Trials, Marketing.
- HQ
- Vancouver, BC
Inventvacc Biologicals Inc Questions
Inventvacc Biologicals Inc's website is http://www.inventvacc.com
Inventvacc Biologicals Inc's LinkedIn profile is https://ca.linkedin.com/company/inventvacc-biologicals-inc
Inventvacc Biologicals Inc has
3 employees.
View email and phone details for 3
employees at Inventvacc Biologicals Inc.
Inventvacc Biologicals Inc's industry is
Biotechnology Research
Inventvacc Biologicals Inc's top competitors are
Agc Biologics,
Malarvx, Inc.,
Eder Therapeutics,
Cellchem Pharmaceuticals Inc.,
Vaxcyte,
Seagen,
Inventprise,
Syninnova Laboratories Inc,
Galenvs Sciences,
Vertex Pharmaceuticals.
Inventvacc Biologicals Inc's categories are Biotechnology Research
Inventvacc Biologicals Inc's founding year is 2016
